Blogs: The Reinvented Pharmacist

Few Compounding Pharmacies Are Accredited

Published Online: Thursday, October 25, 2012
Only about 2% of all compounding pharmacies in the United States have received accreditation from the Pharmacy Compounding Accreditation Board, which conducts on-site inspections of facilities and provides voluntary accreditation. Critics say the lack of oversight puts consumers at risk and that the board is no substitute for the FDA.
In my September Editor’s Note, I suggested that it was a good idea to develop an accreditation program for community pharmacy. A recent article in the Washington Post talks about accreditation of compounding pharmacies and suggests that since so few compounding pharmacies are accredited, stronger governmental oversight is needed—although the article does quote some who feel that more government oversight is not needed. I wonder if the story would be the same if a majority of compounding pharmacies were accredited? I don’t think so.
Although it might be hard to imagine a scenario similar to the current meningitis outbreak in which a community pharmacy’s inappropriate activities would result in so many deaths, I think the outbreak underscores the need for an accreditation program for community pharmacy that inspires broad voluntary participation across the industry. Do you think I am stretching the issue or do you agree with me?
More Pharmacy Times coverage of the compounding pharmacy–associated meningitis outbreak:
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times
Blog Info
This blog focuses on what our Editor-in-Chief sees as the future of pharmacy.
Author Bio
Fred Eckel, RPh, MS, is the Editor-in-Chief of Pharmacy Times, a position he has held since 2002. Mr. Eckel is a professor at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. He serves as executive director of the North Carolina Association of Pharmacists.

In this blog, Eckel will provide commentary on relevant issues impacting pharmacists and pharmacy professionals, including the merging of pharmacy benefit managers, the implications of health care reform, the conversion of major drugs from prescription to over-the-counter, trends in pharmacy careers, and opioid abuse. He will also discuss legislative issues that impact pharmacists, and comment on the evolving role of the pharmacist.
Blog Archive
Latest Issues